Feasibility study of pharmacy-only SF in Poland

A tier 1 global branded generic company wanted to understand the real impact and RoI of its pharmacy sales force. 

Evidence-based differential financial impact modeled by Montecarlo multi-variable analyses provided not just the answer to the question, but also the adjustments needed to optimize this commercial investment of the team to the portfolio type, as well as size of the operations, vs investment in other marketing mix initiatives.  The company increased RoI within 6 months.